Sakaeda T - Search Results

1

O/W lipid emulsions for parenteral drug delivery. I. Pharmacokinetics of the oil particles and incorporated sudan II.

Sakaeda T, Takahashi K, Nishihara Y, Hirano K. Sakaeda T, et al. Biol Pharm Bull. 1994 Nov;17(11):1490-5. doi: 10.1248/bpb.17.1490. Biol Pharm Bull. 1994. PMID: 7703970 Free article.

2

O/W lipid emulsions for parenteral drug delivery. II. Effect of composition on pharmacokinetics of incorporated drug.

Sakaeda T, Hirano K. Sakaeda T, et al. J Drug Target. 1995;3(3):221-30. doi: 10.3109/10611869509015949. J Drug Target. 1995. PMID: 8705256

3

O/W lipid emulsions for parenteral drug delivery. III. Lipophilicity necessary for incorporation in oil particles even after intravenous injection.

Sakaeda T, Hirano K. Sakaeda T, et al. J Drug Target. 1998;6(2):119-27. doi: 10.3109/10611869808997887. J Drug Target. 1998. PMID: 9886236

4

O/W lipid emulsions for parenteral drug delivery. IV. Changes in the pharmacokinetics and pharmacodynamics of a highly lipophilic drug, menatetrenone.

Sakaeda T, Kakushi H, Shike T, Takano K, Harauchi T, Hirata M, Hirano K. Sakaeda T, et al. J Drug Target. 1998;6(3):183-9. doi: 10.3109/10611869808997892. J Drug Target. 1998. PMID: 9888304

5

Effect of composition on biological fate of oil particles after intravenous injection of O/W lipid emulsions.

Sakaeda T, Hirano K. Sakaeda T, et al. J Drug Target. 1998;6(4):273-84. doi: 10.3109/10611869808996835. J Drug Target. 1998. PMID: 9894695

6

Blood flow rate in normal and tumor-bearing rats in conscious state, under urethane anesthesia, and during systemic hypothermia.

Sakaeda T, Fukumura K, Takahashi K, Matsumura S, Matsuura E, Hirano K. Sakaeda T, et al. J Drug Target. 1998;6(4):261-72. doi: 10.3109/10611869808996834. J Drug Target. 1998. PMID: 9894694

7

Conjugation with L-Glutamate for in vivo brain drug delivery.

Sakaeda T, Tada Y, Sugawara T, Ryu T, Hirose F, Yoshikawa T, Hirano K, Kupczyk-Subotkowska L, Siahaan TJ, Audus KL, Stella VJ. Sakaeda T, et al. J Drug Target. 2001;9(1):23-37. doi: 10.3109/10611860108995630. J Drug Target. 2001. PMID: 11378521

8

Biodistribution and pharmacokinetics of O-palmitoyl tilisolol, a lipophilic prodrug of tilisolol, after intravenous administration in rats.

Kawakami S, Ohshima N, Hirayama R, Al MH, Kitahara T, Sakaeda T, Mukai T, Nishida K, Nakamura J, Nakashima M, Sasaki H. Kawakami S, et al. Among authors: sakaeda t. Biol Pharm Bull. 2002 Aug;25(8):1072-6. doi: 10.1248/bpb.25.1072. Biol Pharm Bull. 2002. PMID: 12186412 Free article.

9

Kidney- and site-selective delivery of 5-fluorouracil utilizing the absorption on the kidney surface in rats.

Kawakami S, Horimoto T, Nishida K, Hirayama R, Mukai T, Nakashima M, Sasaki H, Sakaeda T, Nakamura J. Kawakami S, et al. Among authors: sakaeda t. Biol Pharm Bull. 2002 Jul;25(7):928-30. doi: 10.1248/bpb.25.928. Biol Pharm Bull. 2002. PMID: 12132672 Free article.

10

Control of plasma cholesterol-lowering action of probucol with various lipid carrier systems.

Takino T, Koreeda N, Nomura T, Sakaeda T, Yamashita F, Takakura Y, Hashida M. Takino T, et al. Among authors: sakaeda t. Biol Pharm Bull. 1998 May;21(5):492-7. doi: 10.1248/bpb.21.492. Biol Pharm Bull. 1998. PMID: 9635506 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

207 results

Search Page

Filters